Global Human Hepatitis B Immunoglobulin Market Growth 2025-2031
The global Human Hepatitis B Immunoglobulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Human hepatitis B immunoglobulin (HBIG) is a blood-derived product that contains antibodies against the hepatitis B virus (HBV). HBIG is used for both the prevention and treatment of hepatitis B infection. Here is an overview of the prospect for human hepatitis B immunoglobulin:
1. Prevention of hepatitis B transmission: HBIG is administered to individuals at high risk of HBV transmission, such as newborns from HBV-infected mothers, healthcare workers exposed to HBV-positive blood, and individuals who have had close contact with someone infected with HBV. It provides passive immunity by rapidly increasing antibody levels against HBV, reducing the risk of infection.
2. Post-exposure prophylaxis: HBIG can be given as part of post-exposure prophylaxis, especially for individuals who have recently been exposed to HBV and have not been vaccinated or who have low or no immune response to HBV vaccines. It provides immediate protection against HBV infection while the body mounts its immune response.
3. Treatment of acute hepatitis B: HBIG can be used in the treatment of acute hepatitis B infection, especially in cases with severe symptoms or complications. It helps to reduce viral replication, control the infection, and prevent further damage to the liver. HBIG may be used in combination with antiviral medications for optimal treatment outcomes.
4. Pre-transplant and post-transplant prophylaxis: HBIG is often used in individuals undergoing liver transplantation for HBV-related liver disease. Pre-transplant HBIG administration aims to reduce viral load and prevent HBV re-infection of the transplanted liver. Post-transplant HBIG is given to suppress viral replication and provide long-term protection against HBV recurrence.
5. Long-term prophylaxis for chronic hepatitis B: In some cases of chronic hepatitis B infection, long-term HBIG administration may be recommended to maintain protective levels of antibodies and prevent disease progression or reactivation. This is often combined with antiviral medications to achieve the best outcomes.
6. Safety and efficacy: HBIG is derived from blood plasma and undergoes rigorous screening and testing to ensure safety and efficacy. However, as with any blood-derived product, there may be a minimal risk of transmitting infectious agents. The benefits of HBIG in preventing or treating HBV infection usually outweigh the potential risks.
7. Ongoing research and development: Research is ongoing to improve the efficacy, safety, and convenience of HBIG administration. This includes the development of recombinant HBIG and alternative dosing regimens to reduce the volume and frequency of administration.
Overall, the prospect for human hepatitis B immunoglobulin lies in its vital role in preventing HBV transmission, providing immediate protection after exposure, treating acute infection, and managing chronic hepatitis B. Continued research and development will further enhance the benefits and applicability of HBIG, ensuring improved outcomes for individuals at risk of or infected with HBV.
LP Information, Inc. (LPI) ' newest research report, the “Human Hepatitis B Immunoglobulin Industry Forecast” looks at past sales and reviews total world Human Hepatitis B Immunoglobulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Hepatitis B Immunoglobulin sales for 2025 through 2031. With Human Hepatitis B Immunoglobulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Hepatitis B Immunoglobulin industry.
This Insight Report provides a comprehensive analysis of the global Human Hepatitis B Immunoglobulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Hepatitis B Immunoglobulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Hepatitis B Immunoglobulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Hepatitis B Immunoglobulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Hepatitis B Immunoglobulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Hepatitis B Immunoglobulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Human Hepatitis B Immunoglobulin market?
What factors are driving Human Hepatitis B Immunoglobulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Hepatitis B Immunoglobulin market opportunities vary by end market size?
How does Human Hepatitis B Immunoglobulin break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Human hepatitis B immunoglobulin (HBIG) is a blood-derived product that contains antibodies against the hepatitis B virus (HBV). HBIG is used for both the prevention and treatment of hepatitis B infection. Here is an overview of the prospect for human hepatitis B immunoglobulin:
1. Prevention of hepatitis B transmission: HBIG is administered to individuals at high risk of HBV transmission, such as newborns from HBV-infected mothers, healthcare workers exposed to HBV-positive blood, and individuals who have had close contact with someone infected with HBV. It provides passive immunity by rapidly increasing antibody levels against HBV, reducing the risk of infection.
2. Post-exposure prophylaxis: HBIG can be given as part of post-exposure prophylaxis, especially for individuals who have recently been exposed to HBV and have not been vaccinated or who have low or no immune response to HBV vaccines. It provides immediate protection against HBV infection while the body mounts its immune response.
3. Treatment of acute hepatitis B: HBIG can be used in the treatment of acute hepatitis B infection, especially in cases with severe symptoms or complications. It helps to reduce viral replication, control the infection, and prevent further damage to the liver. HBIG may be used in combination with antiviral medications for optimal treatment outcomes.
4. Pre-transplant and post-transplant prophylaxis: HBIG is often used in individuals undergoing liver transplantation for HBV-related liver disease. Pre-transplant HBIG administration aims to reduce viral load and prevent HBV re-infection of the transplanted liver. Post-transplant HBIG is given to suppress viral replication and provide long-term protection against HBV recurrence.
5. Long-term prophylaxis for chronic hepatitis B: In some cases of chronic hepatitis B infection, long-term HBIG administration may be recommended to maintain protective levels of antibodies and prevent disease progression or reactivation. This is often combined with antiviral medications to achieve the best outcomes.
6. Safety and efficacy: HBIG is derived from blood plasma and undergoes rigorous screening and testing to ensure safety and efficacy. However, as with any blood-derived product, there may be a minimal risk of transmitting infectious agents. The benefits of HBIG in preventing or treating HBV infection usually outweigh the potential risks.
7. Ongoing research and development: Research is ongoing to improve the efficacy, safety, and convenience of HBIG administration. This includes the development of recombinant HBIG and alternative dosing regimens to reduce the volume and frequency of administration.
Overall, the prospect for human hepatitis B immunoglobulin lies in its vital role in preventing HBV transmission, providing immediate protection after exposure, treating acute infection, and managing chronic hepatitis B. Continued research and development will further enhance the benefits and applicability of HBIG, ensuring improved outcomes for individuals at risk of or infected with HBV.
LP Information, Inc. (LPI) ' newest research report, the “Human Hepatitis B Immunoglobulin Industry Forecast” looks at past sales and reviews total world Human Hepatitis B Immunoglobulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Hepatitis B Immunoglobulin sales for 2025 through 2031. With Human Hepatitis B Immunoglobulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Hepatitis B Immunoglobulin industry.
This Insight Report provides a comprehensive analysis of the global Human Hepatitis B Immunoglobulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Hepatitis B Immunoglobulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Hepatitis B Immunoglobulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Hepatitis B Immunoglobulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Hepatitis B Immunoglobulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Hepatitis B Immunoglobulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
- 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
- 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
- Hepatitis B Carrier
- Hepatitis B Close Contacts
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- CSL
- Bayer
- Grifols
- Octapharma
- Shanghai RAAS
- Hualan Biological
- China Biologic
- Tiantan Biologic
- Shuanglin Bio-pharmacy
- Sichuan Yuanda Shuyang
- Boya Bio-pharmaceutical
- Shanghai Institute of Biological
What is the 10-year outlook for the global Human Hepatitis B Immunoglobulin market?
What factors are driving Human Hepatitis B Immunoglobulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Hepatitis B Immunoglobulin market opportunities vary by end market size?
How does Human Hepatitis B Immunoglobulin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Hepatitis B Immunoglobulin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Hepatitis B Immunoglobulin by Country/Region, 2020, 2024 & 2031
2.2 Human Hepatitis B Immunoglobulin Segment by Type
2.2.1 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.2.2 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.2.3 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.3 Human Hepatitis B Immunoglobulin Sales by Type
2.3.1 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
2.3.2 Global Human Hepatitis B Immunoglobulin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Hepatitis B Immunoglobulin Sale Price by Type (2020-2025)
2.4 Human Hepatitis B Immunoglobulin Segment by Application
2.4.1 Hepatitis B Carrier
2.4.2 Hepatitis B Close Contacts
2.5 Human Hepatitis B Immunoglobulin Sales by Application
2.5.1 Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2020-2025)
2.5.2 Global Human Hepatitis B Immunoglobulin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Hepatitis B Immunoglobulin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Hepatitis B Immunoglobulin Breakdown Data by Company
3.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Company (2020-2025)
3.1.2 Global Human Hepatitis B Immunoglobulin Sales Market Share by Company (2020-2025)
3.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Company (2020-2025)
3.2.1 Global Human Hepatitis B Immunoglobulin Revenue by Company (2020-2025)
3.2.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2020-2025)
3.3 Global Human Hepatitis B Immunoglobulin Sale Price by Company
3.4 Key Manufacturers Human Hepatitis B Immunoglobulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Hepatitis B Immunoglobulin Product Location Distribution
3.4.2 Players Human Hepatitis B Immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN HEPATITIS B IMMUNOGLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Human Hepatitis B Immunoglobulin Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Hepatitis B Immunoglobulin Market Size by Country/Region (2020-2025)
4.2.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Hepatitis B Immunoglobulin Sales Growth
4.4 APAC Human Hepatitis B Immunoglobulin Sales Growth
4.5 Europe Human Hepatitis B Immunoglobulin Sales Growth
4.6 Middle East & Africa Human Hepatitis B Immunoglobulin Sales Growth
5 AMERICAS
5.1 Americas Human Hepatitis B Immunoglobulin Sales by Country
5.1.1 Americas Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
5.1.2 Americas Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
5.2 Americas Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
5.3 Americas Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Hepatitis B Immunoglobulin Sales by Region
6.1.1 APAC Human Hepatitis B Immunoglobulin Sales by Region (2020-2025)
6.1.2 APAC Human Hepatitis B Immunoglobulin Revenue by Region (2020-2025)
6.2 APAC Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
6.3 APAC Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Hepatitis B Immunoglobulin by Country
7.1.1 Europe Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
7.1.2 Europe Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
7.2 Europe Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
7.3 Europe Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Hepatitis B Immunoglobulin by Country
8.1.1 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
8.3 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin
10.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
10.4 Industry Chain Structure of Human Hepatitis B Immunoglobulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Hepatitis B Immunoglobulin Distributors
11.3 Human Hepatitis B Immunoglobulin Customer
12 WORLD FORECAST REVIEW FOR HUMAN HEPATITIS B IMMUNOGLOBULIN BY GEOGRAPHIC REGION
12.1 Global Human Hepatitis B Immunoglobulin Market Size Forecast by Region
12.1.1 Global Human Hepatitis B Immunoglobulin Forecast by Region (2026-2031)
12.1.2 Global Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Hepatitis B Immunoglobulin Forecast by Type (2026-2031)
12.7 Global Human Hepatitis B Immunoglobulin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.1.3 Baxter Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.2.3 CSL Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.3.3 Bayer Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.4.3 Grifols Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Octapharma
13.5.1 Octapharma Company Information
13.5.2 Octapharma Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.5.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Octapharma Main Business Overview
13.5.5 Octapharma Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Hualan Biological
13.7.1 Hualan Biological Company Information
13.7.2 Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Biological Main Business Overview
13.7.5 Hualan Biological Latest Developments
13.8 China Biologic
13.8.1 China Biologic Company Information
13.8.2 China Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.8.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 China Biologic Main Business Overview
13.8.5 China Biologic Latest Developments
13.9 Tiantan Biologic
13.9.1 Tiantan Biologic Company Information
13.9.2 Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Tiantan Biologic Main Business Overview
13.9.5 Tiantan Biologic Latest Developments
13.10 Shuanglin Bio-pharmacy
13.10.1 Shuanglin Bio-pharmacy Company Information
13.10.2 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shuanglin Bio-pharmacy Main Business Overview
13.10.5 Shuanglin Bio-pharmacy Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 Boya Bio-pharmaceutical
13.12.1 Boya Bio-pharmaceutical Company Information
13.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Boya Bio-pharmaceutical Main Business Overview
13.12.5 Boya Bio-pharmaceutical Latest Developments
13.13 Shanghai Institute of Biological
13.13.1 Shanghai Institute of Biological Company Information
13.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai Institute of Biological Main Business Overview
13.13.5 Shanghai Institute of Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Hepatitis B Immunoglobulin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Hepatitis B Immunoglobulin by Country/Region, 2020, 2024 & 2031
2.2 Human Hepatitis B Immunoglobulin Segment by Type
2.2.1 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.2.2 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.2.3 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
2.3 Human Hepatitis B Immunoglobulin Sales by Type
2.3.1 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
2.3.2 Global Human Hepatitis B Immunoglobulin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Hepatitis B Immunoglobulin Sale Price by Type (2020-2025)
2.4 Human Hepatitis B Immunoglobulin Segment by Application
2.4.1 Hepatitis B Carrier
2.4.2 Hepatitis B Close Contacts
2.5 Human Hepatitis B Immunoglobulin Sales by Application
2.5.1 Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2020-2025)
2.5.2 Global Human Hepatitis B Immunoglobulin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Hepatitis B Immunoglobulin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Hepatitis B Immunoglobulin Breakdown Data by Company
3.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Company (2020-2025)
3.1.2 Global Human Hepatitis B Immunoglobulin Sales Market Share by Company (2020-2025)
3.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Company (2020-2025)
3.2.1 Global Human Hepatitis B Immunoglobulin Revenue by Company (2020-2025)
3.2.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2020-2025)
3.3 Global Human Hepatitis B Immunoglobulin Sale Price by Company
3.4 Key Manufacturers Human Hepatitis B Immunoglobulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Hepatitis B Immunoglobulin Product Location Distribution
3.4.2 Players Human Hepatitis B Immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN HEPATITIS B IMMUNOGLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Human Hepatitis B Immunoglobulin Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Hepatitis B Immunoglobulin Market Size by Country/Region (2020-2025)
4.2.1 Global Human Hepatitis B Immunoglobulin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Hepatitis B Immunoglobulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Hepatitis B Immunoglobulin Sales Growth
4.4 APAC Human Hepatitis B Immunoglobulin Sales Growth
4.5 Europe Human Hepatitis B Immunoglobulin Sales Growth
4.6 Middle East & Africa Human Hepatitis B Immunoglobulin Sales Growth
5 AMERICAS
5.1 Americas Human Hepatitis B Immunoglobulin Sales by Country
5.1.1 Americas Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
5.1.2 Americas Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
5.2 Americas Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
5.3 Americas Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Hepatitis B Immunoglobulin Sales by Region
6.1.1 APAC Human Hepatitis B Immunoglobulin Sales by Region (2020-2025)
6.1.2 APAC Human Hepatitis B Immunoglobulin Revenue by Region (2020-2025)
6.2 APAC Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
6.3 APAC Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Hepatitis B Immunoglobulin by Country
7.1.1 Europe Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
7.1.2 Europe Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
7.2 Europe Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
7.3 Europe Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Hepatitis B Immunoglobulin by Country
8.1.1 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2020-2025)
8.3 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin
10.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
10.4 Industry Chain Structure of Human Hepatitis B Immunoglobulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Hepatitis B Immunoglobulin Distributors
11.3 Human Hepatitis B Immunoglobulin Customer
12 WORLD FORECAST REVIEW FOR HUMAN HEPATITIS B IMMUNOGLOBULIN BY GEOGRAPHIC REGION
12.1 Global Human Hepatitis B Immunoglobulin Market Size Forecast by Region
12.1.1 Global Human Hepatitis B Immunoglobulin Forecast by Region (2026-2031)
12.1.2 Global Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Hepatitis B Immunoglobulin Forecast by Type (2026-2031)
12.7 Global Human Hepatitis B Immunoglobulin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.1.3 Baxter Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.2.3 CSL Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.3.3 Bayer Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.4.3 Grifols Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Octapharma
13.5.1 Octapharma Company Information
13.5.2 Octapharma Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.5.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Octapharma Main Business Overview
13.5.5 Octapharma Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Hualan Biological
13.7.1 Hualan Biological Company Information
13.7.2 Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Biological Main Business Overview
13.7.5 Hualan Biological Latest Developments
13.8 China Biologic
13.8.1 China Biologic Company Information
13.8.2 China Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.8.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 China Biologic Main Business Overview
13.8.5 China Biologic Latest Developments
13.9 Tiantan Biologic
13.9.1 Tiantan Biologic Company Information
13.9.2 Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Tiantan Biologic Main Business Overview
13.9.5 Tiantan Biologic Latest Developments
13.10 Shuanglin Bio-pharmacy
13.10.1 Shuanglin Bio-pharmacy Company Information
13.10.2 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shuanglin Bio-pharmacy Main Business Overview
13.10.5 Shuanglin Bio-pharmacy Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 Boya Bio-pharmaceutical
13.12.1 Boya Bio-pharmaceutical Company Information
13.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Boya Bio-pharmaceutical Main Business Overview
13.12.5 Boya Bio-pharmaceutical Latest Developments
13.13 Shanghai Institute of Biological
13.13.1 Shanghai Institute of Biological Company Information
13.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
13.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai Institute of Biological Main Business Overview
13.13.5 Shanghai Institute of Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Hepatitis B Immunoglobulin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Hepatitis B Immunoglobulin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 4. Major Players of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 5. Major Players of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 6. Global Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 7. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Table 8. Global Human Hepatitis B Immunoglobulin Revenue by Type (2020-2025) & ($ million)
Table 9. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2020-2025)
Table 10. Global Human Hepatitis B Immunoglobulin Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Human Hepatitis B Immunoglobulin Sale by Application (2020-2025) & (K Units)
Table 12. Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2020-2025)
Table 13. Global Human Hepatitis B Immunoglobulin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2020-2025)
Table 15. Global Human Hepatitis B Immunoglobulin Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Human Hepatitis B Immunoglobulin Sales by Company (2020-2025) & (K Units)
Table 17. Global Human Hepatitis B Immunoglobulin Sales Market Share by Company (2020-2025)
Table 18. Global Human Hepatitis B Immunoglobulin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2020-2025)
Table 20. Global Human Hepatitis B Immunoglobulin Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Human Hepatitis B Immunoglobulin Producing Area Distribution and Sales Area
Table 22. Players Human Hepatitis B Immunoglobulin Products Offered
Table 23. Human Hepatitis B Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Human Hepatitis B Immunoglobulin Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Human Hepatitis B Immunoglobulin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Human Hepatitis B Immunoglobulin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Human Hepatitis B Immunoglobulin Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Human Hepatitis B Immunoglobulin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 35. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Country (2020-2025)
Table 36. Americas Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 38. Americas Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 39. APAC Human Hepatitis B Immunoglobulin Sales by Region (2020-2025) & (K Units)
Table 40. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Region (2020-2025)
Table 41. APAC Human Hepatitis B Immunoglobulin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 43. APAC Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 44. Europe Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 45. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 47. Europe Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Human Hepatitis B Immunoglobulin
Table 53. Key Market Challenges & Risks of Human Hepatitis B Immunoglobulin
Table 54. Key Industry Trends of Human Hepatitis B Immunoglobulin
Table 55. Human Hepatitis B Immunoglobulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Human Hepatitis B Immunoglobulin Distributors List
Table 58. Human Hepatitis B Immunoglobulin Customer List
Table 59. Global Human Hepatitis B Immunoglobulin Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Human Hepatitis B Immunoglobulin Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Human Hepatitis B Immunoglobulin Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Human Hepatitis B Immunoglobulin Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Baxter Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 75. Baxter Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. CSL Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 80. CSL Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. Bayer Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 85. Bayer Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Grifols Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 90. Grifols Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Octapharma Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 95. Octapharma Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Shanghai RAAS Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 100. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Shanghai RAAS Main Business
Table 102. Shanghai RAAS Latest Developments
Table 103. Hualan Biological Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 105. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Hualan Biological Main Business
Table 107. Hualan Biological Latest Developments
Table 108. China Biologic Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 109. China Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 110. China Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. China Biologic Main Business
Table 112. China Biologic Latest Developments
Table 113. Tiantan Biologic Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 115. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Tiantan Biologic Main Business
Table 117. Tiantan Biologic Latest Developments
Table 118. Shuanglin Bio-pharmacy Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 120. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Shuanglin Bio-pharmacy Main Business
Table 122. Shuanglin Bio-pharmacy Latest Developments
Table 123. Sichuan Yuanda Shuyang Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 125. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Sichuan Yuanda Shuyang Main Business
Table 127. Sichuan Yuanda Shuyang Latest Developments
Table 128. Boya Bio-pharmaceutical Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 130. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Boya Bio-pharmaceutical Main Business
Table 132. Boya Bio-pharmaceutical Latest Developments
Table 133. Shanghai Institute of Biological Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 135. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Shanghai Institute of Biological Main Business
Table 137. Shanghai Institute of Biological Latest Developments
Table 1. Human Hepatitis B Immunoglobulin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Hepatitis B Immunoglobulin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 4. Major Players of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 5. Major Players of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Table 6. Global Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 7. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Table 8. Global Human Hepatitis B Immunoglobulin Revenue by Type (2020-2025) & ($ million)
Table 9. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2020-2025)
Table 10. Global Human Hepatitis B Immunoglobulin Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Human Hepatitis B Immunoglobulin Sale by Application (2020-2025) & (K Units)
Table 12. Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2020-2025)
Table 13. Global Human Hepatitis B Immunoglobulin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2020-2025)
Table 15. Global Human Hepatitis B Immunoglobulin Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Human Hepatitis B Immunoglobulin Sales by Company (2020-2025) & (K Units)
Table 17. Global Human Hepatitis B Immunoglobulin Sales Market Share by Company (2020-2025)
Table 18. Global Human Hepatitis B Immunoglobulin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company (2020-2025)
Table 20. Global Human Hepatitis B Immunoglobulin Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Human Hepatitis B Immunoglobulin Producing Area Distribution and Sales Area
Table 22. Players Human Hepatitis B Immunoglobulin Products Offered
Table 23. Human Hepatitis B Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Human Hepatitis B Immunoglobulin Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Human Hepatitis B Immunoglobulin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Human Hepatitis B Immunoglobulin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Human Hepatitis B Immunoglobulin Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Human Hepatitis B Immunoglobulin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 35. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Country (2020-2025)
Table 36. Americas Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 38. Americas Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 39. APAC Human Hepatitis B Immunoglobulin Sales by Region (2020-2025) & (K Units)
Table 40. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Region (2020-2025)
Table 41. APAC Human Hepatitis B Immunoglobulin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 43. APAC Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 44. Europe Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 45. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 47. Europe Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Human Hepatitis B Immunoglobulin
Table 53. Key Market Challenges & Risks of Human Hepatitis B Immunoglobulin
Table 54. Key Industry Trends of Human Hepatitis B Immunoglobulin
Table 55. Human Hepatitis B Immunoglobulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Human Hepatitis B Immunoglobulin Distributors List
Table 58. Human Hepatitis B Immunoglobulin Customer List
Table 59. Global Human Hepatitis B Immunoglobulin Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Human Hepatitis B Immunoglobulin Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Human Hepatitis B Immunoglobulin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Human Hepatitis B Immunoglobulin Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Human Hepatitis B Immunoglobulin Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Human Hepatitis B Immunoglobulin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Baxter Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 75. Baxter Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. CSL Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 80. CSL Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. Bayer Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 85. Bayer Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Grifols Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 90. Grifols Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Octapharma Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 95. Octapharma Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Shanghai RAAS Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 100. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Shanghai RAAS Main Business
Table 102. Shanghai RAAS Latest Developments
Table 103. Hualan Biological Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 105. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Hualan Biological Main Business
Table 107. Hualan Biological Latest Developments
Table 108. China Biologic Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 109. China Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 110. China Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. China Biologic Main Business
Table 112. China Biologic Latest Developments
Table 113. Tiantan Biologic Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 115. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Tiantan Biologic Main Business
Table 117. Tiantan Biologic Latest Developments
Table 118. Shuanglin Bio-pharmacy Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 120. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Shuanglin Bio-pharmacy Main Business
Table 122. Shuanglin Bio-pharmacy Latest Developments
Table 123. Sichuan Yuanda Shuyang Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 125. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Sichuan Yuanda Shuyang Main Business
Table 127. Sichuan Yuanda Shuyang Latest Developments
Table 128. Boya Bio-pharmaceutical Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 130. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Boya Bio-pharmaceutical Main Business
Table 132. Boya Bio-pharmaceutical Latest Developments
Table 133. Shanghai Institute of Biological Basic Information, Human Hepatitis B Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolios and Specifications
Table 135. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Shanghai Institute of Biological Main Business
Table 137. Shanghai Institute of Biological Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Hepatitis B Immunoglobulin
Figure 2. Human Hepatitis B Immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Hepatitis B Immunoglobulin Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Hepatitis B Immunoglobulin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Hepatitis B Immunoglobulin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2024)
Figure 10. Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 12. Product Picture of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 13. Product Picture of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 14. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2025
Figure 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2020-2025)
Figure 16. Human Hepatitis B Immunoglobulin Consumed in Hepatitis B Carrier
Figure 17. Global Human Hepatitis B Immunoglobulin Market: Hepatitis B Carrier (2020-2025) & (K Units)
Figure 18. Human Hepatitis B Immunoglobulin Consumed in Hepatitis B Close Contacts
Figure 19. Global Human Hepatitis B Immunoglobulin Market: Hepatitis B Close Contacts (2020-2025) & (K Units)
Figure 20. Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2024)
Figure 21. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application in 2025
Figure 22. Human Hepatitis B Immunoglobulin Sales by Company in 2025 (K Units)
Figure 23. Global Human Hepatitis B Immunoglobulin Sales Market Share by Company in 2025
Figure 24. Human Hepatitis B Immunoglobulin Revenue by Company in 2025 ($ millions)
Figure 25. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company in 2025
Figure 26. Global Human Hepatitis B Immunoglobulin Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 29. Americas Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 30. APAC Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 31. APAC Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 32. Europe Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 33. Europe Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 36. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2025
Figure 37. Americas Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Figure 38. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 39. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 40. United States Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Region in 2025
Figure 45. APAC Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2020-2025)
Figure 46. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 47. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 48. China Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 52. India Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2025
Figure 56. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Figure 57. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 58. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 59. Germany Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 60. France Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 67. Egypt Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin in 2025
Figure 73. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
Figure 74. Industry Chain Structure of Human Hepatitis B Immunoglobulin
Figure 75. Channels of Distribution
Figure 76. Global Human Hepatitis B Immunoglobulin Sales Market Forecast by Region (2026-2031)
Figure 77. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Hepatitis B Immunoglobulin
Figure 2. Human Hepatitis B Immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Hepatitis B Immunoglobulin Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Hepatitis B Immunoglobulin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Hepatitis B Immunoglobulin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2024)
Figure 10. Human Hepatitis B Immunoglobulin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 12. Product Picture of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 13. Product Picture of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 14. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2025
Figure 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2020-2025)
Figure 16. Human Hepatitis B Immunoglobulin Consumed in Hepatitis B Carrier
Figure 17. Global Human Hepatitis B Immunoglobulin Market: Hepatitis B Carrier (2020-2025) & (K Units)
Figure 18. Human Hepatitis B Immunoglobulin Consumed in Hepatitis B Close Contacts
Figure 19. Global Human Hepatitis B Immunoglobulin Market: Hepatitis B Close Contacts (2020-2025) & (K Units)
Figure 20. Global Human Hepatitis B Immunoglobulin Sale Market Share by Application (2024)
Figure 21. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application in 2025
Figure 22. Human Hepatitis B Immunoglobulin Sales by Company in 2025 (K Units)
Figure 23. Global Human Hepatitis B Immunoglobulin Sales Market Share by Company in 2025
Figure 24. Human Hepatitis B Immunoglobulin Revenue by Company in 2025 ($ millions)
Figure 25. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Company in 2025
Figure 26. Global Human Hepatitis B Immunoglobulin Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 29. Americas Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 30. APAC Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 31. APAC Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 32. Europe Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 33. Europe Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Human Hepatitis B Immunoglobulin Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue 2020-2025 ($ millions)
Figure 36. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2025
Figure 37. Americas Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Figure 38. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 39. Americas Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 40. United States Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Region in 2025
Figure 45. APAC Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2020-2025)
Figure 46. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 47. APAC Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 48. China Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 52. India Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country in 2025
Figure 56. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2020-2025)
Figure 57. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 58. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 59. Germany Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 60. France Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Application (2020-2025)
Figure 67. Egypt Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Human Hepatitis B Immunoglobulin Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin in 2025
Figure 73. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin
Figure 74. Industry Chain Structure of Human Hepatitis B Immunoglobulin
Figure 75. Channels of Distribution
Figure 76. Global Human Hepatitis B Immunoglobulin Sales Market Forecast by Region (2026-2031)
Figure 77. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Human Hepatitis B Immunoglobulin Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Human Hepatitis B Immunoglobulin Revenue Market Share Forecast by Application (2026-2031)
